Skip to main content

Agalsidase beta for Fabry disease: What is it? How does it work? Who shouldn't take it? Side effects? Efficacy? Evidence? Research studies?

Fabry disease is a rare genetic disease which is caused by a deficiency of a certain enzyme called alpha-galactosidase A (AGA). An AGA deficiency leads to the buildup of a certain type of fat called GL-3 in tissues, which causes a variety of symptoms and can present itself in different ways. Agalsidase beta is an enzyme replacement therapy that is used to treat the disease. 

Fabry disease is a X-linked lysosomal storage disorder which is caused by mutations in the GLA gene. The GLA gene is the one that codes for AGA. The enzyme is crucial for breakdown of GL-3. When GL-3 builds up in cells due to the deficiency caused by Fabry disease, the patients experience symptoms like pain in hands and feet, rashes, very low amounts of sweat, opacity in the cornea (vision problems), GI issues, and kidney damage. 

Agalsidase beta replacement therapy works by replacing the deficiency enzyme and therefore causing a reduction in GL-3 accumulation. It provides the functional enzyme to the body and allows the body to breakdown GL-3, restoring bodily health and preventing further damage to the cells. It is administered through IV infusions, in dosages of 1mg/kg every two weeks. Each infusion takes around 4 hours and is heavily monitored in a clinical setting to prevent any adverse reactions. 

These adverse reactions arise due to hypersensitivity to the enzyme or being pregnant. When one is hypersensitive, their body may not be able to adjust to the immediate spike in the enzyme concentration, and react badly. On the other hand, for pregnant females, the effect of agalsidase beta is not yet well established or studied, making it difficult to predict whether it is a safe medicine for the developing fetus. 

Common side effects include chills/fever which is managed with antihistamines or corticosteroids, or in some cases, pain/fatigue/upper respiratory infections which are usually treated with a pause in the supply of medicine and symptomatic treatment. 

The efficacy of agalsidase beta to treat GL-3 accumulation is very high, as is seen through the research study, "Efficacy and safety of agalsidase beta in patients with Fabry disease: a randomized controlled trial" which found that it reduced GL-3 levels in the kidneys, skin and even the heart. Thus, leading to improvements in pain, renal codition and cardiac output. 

Comments

Post a Comment

Please add your name when you comment down below!

Popular posts from this blog

The top 4 diets for PCOS: DASH diet, high protein diet, reduced calorie diet, and the keto diet. Which is better?

 PCOS is a  condition wherein people have imbalanced hormone levels. These imbalances present themselves in the form of polycystic ovaries, chronic irregular periods, and higher levels of testosterone in the form of increased body/facial hair. Among people who have PCOS, 80% of patients will hold fat around their belly and gain weight because of the effects of hormonal imbalances on their bodies. These effects include insulin resistance, gut dysbiosis, low-grade inflammation and more.  To treat this weight gain, doctors tend to recommend different diets to PCOS patients. But, the efficacy of these diets are heavily dependent on the person's individual situation. There are four major dietary approaches used to lose weight for people with PCOS: Reduced calorie diets, DASH diets, high protein diets, and keto diets. For most people, a combination of all of these diets will work best.  Here's a short explanation of each of these diets:  1) Reduced calorie diet: You e...
Post a Comment
Read more

Eliglustat for Gaucher disease: How does it work? How is it consumed? Side effects? Is it safe? Efficacy? Research? Evidence?

Gaucher disease is a rare genetic disorder wherein the body lacks the ability to break down a specific kind of fat, which leads to accumulation thereof around various parts of the body, such as organs and bones. Eliglustat is one of the most common medications prescribed to help treat the disease by reducing production of the fat itself.  The disease is an inherited lysosomal storage disorder which is caused by an enzyme deficiency, specifically a low level of glucocerebrosidase. This enzyme breaks down a fat with a similar name, glucocerebroside. When the body lacks production of the enzyme, the fat accumulates around and in cells of the spleen, liver, and bone marrow. This causes a variety of symptoms in patients, and can present itself in bizarre ways like: enlarged spleens and livers, increased bone pain and occurrence of fractures, fatigue, anemia and even increased bruising.  Eliglustat, the medicine provided to patients, works in one way: substrate reduction. Basically,...
Post a Comment
Read more

How does oxymetazoline work to clear your nasal passages?

Oxymetazoline Hydrochloride is a topical nasal decongestant that is often found in most OTC nasal sprays like Otrivin in India. It works quite effectively with regards to relieving people from nasal congestion caused by things like colds, allergies, or sinusitis by constricting blood vessels in the nasal passages. The medication is an alpha-adrenergic receptor binder, meaning that it binds to the alpha-adrenergic receptors. These receptors are found on the smooth muscle cells which line blood vessels in the nasal mucosa. When oxymetazoline is applied to the nasal mucosa through droplets, it stimulates the receptors and triggers them to cause constriction of nasal blood vessels. Through vasoconstriction, there is a reduce in blood flow to the region, causing decreased swelling and inflammation. It also reduces how much mucus is produced, since it reduces the quantity of fluid that leaks into the passages. Thus, air can flow more freely in the passage, providing relief from the blocked n...
Post a Comment
Read more